15 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34810175 | PAX-D: study protocol for a randomised placebo-controlled trial evaluating the efficacy and mechanism of pramipexole as add-on treatment for people with treatment resistant depression. | 2022 May | 1 |
2 | 35605609 | Enhanced taste recognition following subacute treatment with the dopamine D2/D3 receptor agonist pramipexole in healthy volunteers. | 2022 May 23 | 1 |
3 | 33264473 | Dopamine and ghrelin receptor co-expression and interaction in the spinal defecation centers. | 2021 May | 1 |
4 | 34451897 | An Experimental Medicine Investigation of the Effects of Subacute Pramipexole Treatment on Emotional Information Processing in Healthy Volunteers. | 2021 Aug 14 | 1 |
5 | 31235613 | Pramipexole prevents ischemic cell death via mitochondrial pathways in ischemic stroke. | 2019 Aug 29 | 1 |
6 | 31324936 | Computational modelling reveals contrasting effects on reinforcement learning and cognitive flexibility in stimulant use disorder and obsessive-compulsive disorder: remediating effects of dopaminergic D2/3 receptor agents. | 2019 Aug | 1 |
7 | 21408026 | Binding of pramipexole to extrastriatal dopamine D2/D3 receptors in the human brain: a positron emission tomography study using 11C-FLB 457. | 2011 Mar 9 | 1 |
8 | 19396436 | Association of the DRD2 and DRD3 polymorphisms with response to pramipexole in Parkinson's disease patients. | 2009 Jul | 2 |
9 | 17161393 | Novel neuroprotective mechanisms of pramipexole, an anti-Parkinson drug, against endogenous dopamine-mediated excitotoxicity. | 2007 Feb 28 | 1 |
10 | 12737528 | Neuroprotective mechanisms of antiparkinsonian dopamine D2-receptor subfamily agonists. | 2003 Jul | 1 |
11 | 10812530 | Comparison of pramipexole, fluoxetine, and placebo in patients with major depression. | 2000 | 1 |
12 | 11054154 | Pre-clinical studies of pramipexole: clinical relevance. | 2000 May | 1 |
13 | 10201413 | Efficacy, safety, and tolerance of the non-ergoline dopamine agonist pramipexole in the treatment of advanced Parkinson's disease: a double blind, placebo controlled, randomised, multicentre study. | 1999 Apr | 1 |
14 | 8665547 | Pramipexole in patients with early Parkinson's disease. | 1995 Aug | 1 |
15 | 8748629 | The use of pramipexole, a novel dopamine (DA) agonist, in advanced Parkinson's disease. | 1995 | 1 |